Tuvusertib
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Tuvusertib, covering 2024-09-27 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Tuvusertib (M1774) Human Mass Balance and Absolute Bioavailability Study (DDRIVER Solid Tumors 303) [Phase 1]